Annual ROE
-182.44%
-48.22%-35.93%
December 31, 2023
Summary
- As of February 7, 2025, NVCT annual return on equity is -182.44%, with the most recent change of -48.22% (-35.93%) on December 31, 2023.
- NVCT annual ROE is now -255.80% below its all-time high of 117.10%, reached on December 31, 2021.
Performance
NVCT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-155.80%
-3.54%-2.32%
September 30, 2024
Summary
- As of February 7, 2025, NVCT quarterly return on equity is -155.80%, with the most recent change of -3.54% (-2.32%) on September 30, 2024.
- Over the past year, NVCT quarterly ROE has dropped by -15.14% (-10.76%).
- NVCT quarterly ROE is now -124.10% below its all-time high of 646.56%, reached on March 31, 2022.
Performance
NVCT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NVCT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.9% | -10.8% |
| 3 y3 years | - | -10.8% |
| 5 y5 years | - | -10.8% |
NVCT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -255.8% | at low | -124.1% | +82.3% |
| 5 y | 5-year | -255.8% | at low | -124.1% | +82.3% |
| alltime | all time | -255.8% | at low | -124.1% | +82.3% |
Nuvectis Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -155.80%(+2.3%) |
| Jun 2024 | - | -152.26%(+7.6%) |
| Mar 2024 | - | -141.57%(-2.2%) |
| Dec 2023 | -182.44%(+35.9%) | -144.80%(+2.9%) |
| Sep 2023 | - | -140.66%(+5.8%) |
| Jun 2023 | - | -132.92%(-3.9%) |
| Mar 2023 | - | -138.37%(+9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -134.22%(-214.6%) | -125.87%(-23.9%) |
| Sep 2022 | - | -165.42%(-81.2%) |
| Jun 2022 | - | -878.64%(-235.9%) |
| Mar 2022 | - | 646.56%(+307.0%) |
| Dec 2021 | 117.10% | 158.87%(-0.4%) |
| Sep 2021 | - | 159.45%(+17.7%) |
| Jun 2021 | - | 135.48% |
FAQ
- What is Nuvectis Pharma annual return on equity?
- What is the all time high annual ROE for Nuvectis Pharma?
- What is Nuvectis Pharma annual ROE year-on-year change?
- What is Nuvectis Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly ROE year-on-year change?
What is Nuvectis Pharma annual return on equity?
The current annual ROE of NVCT is -182.44%
What is the all time high annual ROE for Nuvectis Pharma?
Nuvectis Pharma all-time high annual return on equity is 117.10%
What is Nuvectis Pharma annual ROE year-on-year change?
Over the past year, NVCT annual return on equity has changed by -48.22% (-35.93%)
What is Nuvectis Pharma quarterly return on equity?
The current quarterly ROE of NVCT is -155.80%
What is the all time high quarterly ROE for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly return on equity is 646.56%
What is Nuvectis Pharma quarterly ROE year-on-year change?
Over the past year, NVCT quarterly return on equity has changed by -15.14% (-10.76%)